Literature DB >> 11941496

In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds.

Dieter Rehder1, João Costa Pessoa, Carlos F G C Geraldes, MargaridaM C A Castro, Themistoklis Kabanos, Tamás Kiss, Beate Meier, Giovanni Micera, Lage Pettersson, Maria Rangel, Athanasios Salifoglou, Iztok Turel, Dongren Wang.   

Abstract

A representative set of vanadium(IV and V) compounds in varying coordination environments has been tested in the concentration range 1 to 10(-6) mM, using transformed mice fibroblasts (cell line SV 3T3), with respect to their short-term cell toxicity (up to 36 hours) and their ability to stimulate glucose uptake by cells. These insulin-mimetic tests have also been carried out with non-transformed human fibroblasts (cell line F26). The compounds under investigation comprise established insulin-mimetic species such as vanadate ([H(2)VO(4)](-)), [VO(acetylacetonate)(2)], [VO(2)(dipicolinate)](-) and [VO(maltolate)(2)], and new systems and coordination compounds containing OO, ON, OS, NS and ONS donor atom sets. A vitality test assay, measuring the reduction equivalents released in the mitochondrial respiratory chain by intracellular glucose degradation, is introduced and the results are counter-checked with (3)H-labelled glucose. Most compounds are toxic at the 1 mM concentration level, and most compounds are essentially non-toxic and about as effective as or more potent than insulin at concentrations of 0.01 mM and below. V(V) compounds tend to be less toxic than V(IV)compounds, and complexes containing thio functional ligands are somewhat more toxic than others. Generally, ON ligation is superior in insulin-mimetic efficacy to OO or O/ NS coordination, irrespective of the vanadium oxidation state. There is, however, no striking correlation between the nature of the ligand systems and the insulin-mimetic potency in these cell culture tests, encompassing 41 vanadium compounds, the results on 22 of which are reported in detail here. The syntheses and characteristics of various new compounds are provided together with selected speciation results. The crystal and molecular structures of [[VO(naph-tris)](2)] [where naph-tris is the Schiff base formed between o-hydroxynaphthaldehyde and tris(hydroxymethyl)amine] are reported. Electronic supplementary material to this paper can be obtained by using the Springer Link server located at http://dx.doi.org/10.1007/s00775-001-0311-5.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11941496     DOI: 10.1007/s00775-001-0311-5

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  18 in total

1.  Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.

Authors:  I E León; J F Cadavid-Vargas; I Tiscornia; V Porro; S Castelli; P Katkar; A Desideri; M Bollati-Fogolin; S B Etcheverry
Journal:  J Biol Inorg Chem       Date:  2015-09-24       Impact factor: 3.358

2.  ERKs activation and calcium signaling are both required for VEGF induction by vanadium in mouse epidermal Cl41 cells.

Authors:  Jingxia Li; Qiangsong Tong; Xianglin Shi; Max Costa; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

3.  Antidiabetic vanadium compound and membrane interfaces: interface-facilitated metal complex hydrolysis.

Authors:  Debbie C Crans; Samantha Schoeberl; Ernestas Gaidamauskas; Bharat Baruah; Deborah A Roess
Journal:  J Biol Inorg Chem       Date:  2011-06-11       Impact factor: 3.358

4.  Synthesis of vanadium(IV,V) hydroxamic acid complexes and in vivo assessment of their insulin-like activity.

Authors:  Mamoru Haratake; Masashi Fukunaga; Masahiro Ono; Morio Nakayama
Journal:  J Biol Inorg Chem       Date:  2005-04-02       Impact factor: 3.358

5.  A quantitative study of the biotransformation of insulin-enhancing VO(2+) compounds.

Authors:  Daniele Sanna; Péter Buglyó; Giovanni Micera; Eugenio Garribba
Journal:  J Biol Inorg Chem       Date:  2010-03-26       Impact factor: 3.358

6.  Synthesis, structure analysis, solution chemistry, and in vitro insulinomimetic activity of novel oxovanadium(IV) complexes with tripodal ligands containing an imidazole group derived from amino acids.

Authors:  Kenji Kawabe; Takahiro Sasagawa; Yutaka Yoshikawa; Akio Ichimura; Katsumi Kumekawa; Naohisa Yanagihara; Toshikazu Takino; Hiromu Sakurai; Yoshitane Kojima
Journal:  J Biol Inorg Chem       Date:  2003-10-09       Impact factor: 3.358

7.  {2-[1-(2-Amino-2-methyl-propyl-imino)eth-yl]phenolato-κN,N',O}dioxidovanadium(V).

Authors:  Grzegorz Romanowski; Michał Wera; Artur Sikorski
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-01-14

8.  Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes.

Authors:  Gail R Willsky; Lai-Har Chi; Michael Godzala; Paul J Kostyniak; Jason J Smee; Alejandro M Trujillo; Josephine A Alfano; Wenjin Ding; Zihua Hu; Debbie C Crans
Journal:  Coord Chem Rev       Date:  2011-10       Impact factor: 22.315

9.  Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients.

Authors:  Gail R Willsky; Katherine Halvorsen; Michael E Godzala; Lai-Har Chi; Mathew J Most; Peter Kaszynski; Debbie C Crans; Allison B Goldfine; Paul J Kostyniak
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

10.  α-Hydroxy coordination of mononuclear vanadyl citrate, malate and S-citramalate with N-heterocycle ligand, implying a new protonation pathway of iron-vanadium cofactor in nitrogenase.

Authors:  Can-Yu Chen; Mao-Long Chen; Hong-Bin Chen; Hongxin Wang; Stephen P Cramer; Zhao-Hui Zhou
Journal:  J Inorg Biochem       Date:  2014-08-11       Impact factor: 4.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.